Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
PL02 - Plenary 2: Multidisciplinary Approach to the Oligo Paradigm (Live Streamed Session)
- 08:30 - 10:00
- 8/07/2022
- Location: Hall C1
- IASLC CME Accredited
- Type: Plenary
- Track: N/A
- Moderators:Francoise Mornex, Hisao Asamura
-
+
PL02.08 - Radical Modalities for De Novo Oligometastatic Disease - Local Consolidation - Radiation Oncology
Presenter: Daniel Gomez- Abstract
Loading...
-
+
EP05.01 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
-
+
EP05.01-014 - Circulating Tumor DNA to Identify Genomic Biomarkers of Radiation Sensitivity in Locally Advanced Non-Small Cell Lung Cancer
Presenter: Emily Lebow- Abstract
Loading... -
+
EP05.01-025 - Planned Interim Analysis of a Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Lung Cancer
Presenter: Andreas Rimner- Abstract
Loading...
-
+
P1.05 - Early Stage Non-small Cell - Biomarkers
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Early Stage Non-small Cell - Biomarkers
-
+
P1.05-02 - Mutations in CREBBP are Associated with Local Failure after Lung Stereotactic Body Radiation Therapy
Presenter: Victor Chan Ng- Abstract
Loading...
-
+
P2.12 - Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
- 17:15 - 19:15
- 8/08/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
-
+
P2.12-03 - External Validation of a Novel CT-Based Prognostic Radiomic Signature in Patients With Metastatic NSCLC in SWOG S0819 Phase III Randomized Trial
Presenter: Laurent Dercle- Abstract
Loading...
